352 related articles for article (PubMed ID: 17911623)
1. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.
Müller U; Stenzel W; Köhler G; Werner C; Polte T; Hansen G; Schütze N; Straubinger RK; Blessing M; McKenzie AN; Brombacher F; Alber G
J Immunol; 2007 Oct; 179(8):5367-77. PubMed ID: 17911623
[TBL] [Abstract][Full Text] [Related]
2. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
Hardison SE; Wozniak KL; Kolls JK; Wormley FL
Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing T(h)2 response.
Müller U; Stenzel W; Piehler D; Grahnert A; Protschka M; Köhler G; Frey O; Held J; Richter T; Eschke M; Kamradt T; Brombacher F; Alber G
Int Immunol; 2013 Aug; 25(8):459-70. PubMed ID: 23532373
[TBL] [Abstract][Full Text] [Related]
5. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
[TBL] [Abstract][Full Text] [Related]
6. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.
Chen GH; Olszewski MA; McDonald RA; Wells JC; Paine R; Huffnagle GB; Toews GB
Am J Pathol; 2007 Mar; 170(3):1028-40. PubMed ID: 17322386
[TBL] [Abstract][Full Text] [Related]
7. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.
Nakamura Y; Sato K; Yamamoto H; Matsumura K; Matsumoto I; Nomura T; Miyasaka T; Ishii K; Kanno E; Tachi M; Yamasaki S; Saijo S; Iwakura Y; Kawakami K
Infect Immun; 2015 Feb; 83(2):671-81. PubMed ID: 25422263
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection.
Gyetko MR; Sud S; Chen GH; Fuller JA; Chensue SW; Toews GB
J Immunol; 2002 Jan; 168(2):801-9. PubMed ID: 11777975
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.
Hardison SE; Ravi S; Wozniak KL; Young ML; Olszewski MA; Wormley FL
Am J Pathol; 2010 Feb; 176(2):774-85. PubMed ID: 20056835
[TBL] [Abstract][Full Text] [Related]
10. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
[TBL] [Abstract][Full Text] [Related]
11. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.
Guillot L; Carroll SF; Homer R; Qureshi ST
Infect Immun; 2008 Oct; 76(10):4745-56. PubMed ID: 18678664
[TBL] [Abstract][Full Text] [Related]
12. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
13. Effect of a CD4-depleting antibody on the development of Cryptococcus neoformans-induced allergic bronchopulmonary mycosis in mice.
Arora S; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2006 Jul; 74(7):4339-48. PubMed ID: 16790808
[TBL] [Abstract][Full Text] [Related]
14. IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.
Szymczak WA; Sellers RS; Pirofski LA
Am J Pathol; 2012 Apr; 180(4):1547-59. PubMed ID: 22342846
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.
Hardison SE; Herrera G; Young ML; Hole CR; Wozniak KL; Wormley FL
J Immunol; 2012 Oct; 189(8):4060-8. PubMed ID: 22984078
[TBL] [Abstract][Full Text] [Related]
16. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.
Arora S; Hernandez Y; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB
J Immunol; 2005 May; 174(10):6346-56. PubMed ID: 15879135
[TBL] [Abstract][Full Text] [Related]
17. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.
Zhang Y; Wang F; Tompkins KC; McNamara A; Jain AV; Moore BB; Toews GB; Huffnagle GB; Olszewski MA
Am J Pathol; 2009 Dec; 175(6):2489-500. PubMed ID: 19893050
[TBL] [Abstract][Full Text] [Related]
18. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
Rivera J; Mukherjee J; Weiss LM; Casadevall A
J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
[TBL] [Abstract][Full Text] [Related]
19. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
20. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
